Jim Cramer's Real Money Radio Recap 7/14

Recap of Jim Cramer's radio show on Friday July 14. Click on a stock ticker for more analysis:

This is a re-broadcast of the Radio program on Friday, April 14, 2006.

Patience is Golden: Crystallex (KRY) - Before buying a stock, Cramer suggests doing homework on a company and trying to anticipate where the market may go at least 6 months into the future. As always, he suggests buying low and selling high, but warns against panic if a stock dips but has a great potential, using KRY as as an example. Although KRY fell from $6 to $5 (and eventually to $2.25) after he suggested buying it, Cramer notes that once KRY gets 18 inches of dirt off the surface, investors will see a huge return on their investment with gold at $600 an ounce.

Hide from Insiders: Merrill Lynch (MER) and Goldman Sachs (GS)- Cramer commented on the news that analysts from MER and GS were arrested for insider trading by warning investors that the SEC has the technology to track every trade, and that anyone who provides or receives illegal insider information will get caught. "Tips are for waiters, and will cause you to lose money," he said.

Bullish calls:

Chesapeake Energy (CHK): Cramer likes this stock and believes that natural gas prices will rise.
Titanium Metals (TIE): This company produces titanium for aircraft and huge purchases by Boeing and Airbus have caused the stock to jump from $8 to $53 in one year. The chairman has bought 50,000 shares, and Cramer predicts that the stock is not finished going up.
Procter & Gamble (PG): Cramer says this company has great growth-potential.
GameStop (GME): Cramer is bullish on this game company, which has been up since it introduced Xbox, and he suggests waiting for it to fall to $43 or $44 before buying

Neutral/Bearish calls:

Zoltek (ZOLT): This stock has jumped from $9 to $21 and Cramer would sell it now.
Johnson & Johnson (JNJ): Cramer says this is a great company, but it has been performing badly and losing out to Amgen.
Martek Biosciences (MATK): This company, which makes micro-algae products and is involved in medical research, has fallen with the rest of the healthcare sector, in spite of the fact that it has some big contracts lined up.

More: Cramer's latest stock picks, including: Mad Money Recap, Lightening Round, Stop Trading and his Radio Show.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.